Mineralys Therapeutics Inc (NAS:MLYS)
$ 25.65 -0.10 (-0.39%) Market Cap: 2.27 Bil Enterprise Value: 1.61 Bil PE Ratio: 0 PB Ratio: 4.11 GF Score: 33/100

Mineralys Therapeutics Inc Annual Shareholders Meeting Transcript

May 21, 2026 / 05:30PM GMT
Release Date Price: $30.23 (+6.33%)
Jon Congleton
Mineralys Therapeutics Inc - President, Chief Executive Officer, Director

Good afternoon. This meeting is called to order.

I'm John Congleton, Chief Executive Officer of Mineralis Therapeutics, Inc. I'd like to welcome each of you to this annual meeting of shareholder stockholders. We appreciate your interest and attendance. Joining me on this call is Adam Levy, our Chief Financial Officer.

This meeting is being held pursuant to written notice mailed to all stockholders of record at the close of business on March 25, 2026, which is the record date determined by the Board of Directors.

All stockholders as of the close of business on that date are entitled to notice of and to vote at this meeting.

I have here an affidavit of mailing certifying that the notice of annual meeting was mailed on or about April 8, 2026, to the company's stockholders of record as of the record date. This document will be included with the minutes of the meeting.

Louis Larsen of L-Squared Elections has been appointed the Inspector of Election for this meeting. Mr.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot